White House launches national security investigation into pharma, semiconductors

The Trump administration disclosed Monday that it had opened an investigation into the effects on national security of importing certain pharmaceuticals, a move widely seen as the prelude to initiating tariffs on prescription drugs. The U.S. Department of Commerce in a Federal Register notice said the probe, known as a Section 232 investigation, began April 1, the...